C
Carlos Cordon-Cardo
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 620
Citations - 91832
Carlos Cordon-Cardo is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 144, co-authored 589 publications receiving 84862 citations. Previous affiliations of Carlos Cordon-Cardo include The Rogosin Institute & Erasmus University Rotterdam.
Papers
More filters
Journal ArticleDOI
SARS‐CoV‐2 infection of kidney tissues from severe COVID‐19 patients
Shawn Radovic,Wen Meng,Luping Chen,Alberto E. Paniz Mondolfi,Clare Bryce,Zachary Grimes,Emilia Mia Sordillo,Carlos Cordon-Cardo,Hai-Song Guo,Yufei Huang,Shou-Jiang Gao +10 more
TL;DR: The mechanism involved in kidney pathology in severe acute respiratory syndrome coronavirus disease 2019 (COVID•19) patients was investigated in this paper , where the authors showed that acute kidney injury is common in COVID•2019 patients, displaying as acute tubular necrosis (ATN) resulting from focal epithelial necrosis and eosinophilia, glomerulosclerosis, and autolysis of renal tubular cells.
Journal ArticleDOI
Applications of artificial intelligence in prostate cancer histopathology.
Dallin Busby,Ralph Grauer,Krunal Pandav,Akshita Khosla,Parag Jain,Mani Menon,G. Kenneth Haines,Carlos Cordon-Cardo,Michael A. Gorin,Ashutosh Tewari +9 more
TL;DR: In this article , the authors describe recent advances and future opportunities for AI in prostate cancer histopathology, and suggest that AI has begun to serve as an initial screening tool, an assistant in the form of a real-time interactive interface during histological analysis, and as a second read system to detect false negative diagnoses.
Journal ArticleDOI
P-glycoprotein expression in retinoblastoma.
Ira J. Dunkel,David H. Abramson,Carlos Cordon-Cardo,Guillermo Chantada,M. T. G. de Dávila,Adriana Fandiño +5 more
TL;DR: Like Krishnakumar et al , the authors found limited expression of P-glycoprotein in retinoblastoma cells since only four of the 18 samples were positive, however, six of 18 samples had P- glycoprotein positivity in tumour associated endothelial cells.
Book ChapterDOI
Treatment of Malignant Melanoma with a Mouse Monoclonal IgG3 Antibody Detecting the Ganglioside GD3
TL;DR: Twelve patients with metastatic melanoma were treated with the IgG3 mouse monoclonal antibody R24 which detects the ganglioside GD3, prominent on the surface of melanoma cells and other cells of neuroectodermal origin.
Selection of Tumor Antigens as Targets for Immune Attack Using Immunohistochemistry : Protein Antigens1'2
TL;DR: The results of the two previous papers provide the basis for selection of multiple cell surface antigens as targets for antibody-mediated attack against these cancers.